NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000042393

Registered date:09/11/2020

Study on postoperative analgesia and delirium after lung surgery

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedThoracoscopic and thoracotomy pulmonary resection, partial lung resection
Date of first enrollment2020/11/10
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)1) Desflurane + ESP (D-ESP) group After general anesthesia is introduced, the surgical position (lateral position) is taken, and then an ESP block is performed under ultrasound guidance (0.25% levobupivacaine 20 ml). Place a catheter under the erector spinae muscles and start intermittent administration (0.25% levobupivacaine). The catheter is removed in the morning 3 days after surgery. During surgery, desflurane and remifentanil are used to maintain anesthesia. 2) Desflurane + epidural block (D-Epi) group An epidural catheter is placed in the upper chest before the introduction of general anesthesia, and continuous administration is started at the same time as the start of surgery. (0.25% levobupivacaine 4ml / hr) The catheter is removed in the morning 3 days after surgery. During surgery, desflurane and remifentanil are used to maintain anesthesia. 3) Remimazolam + ESP (R-ESP) group After general anesthesia is introduced, the surgical position (lateral position) is taken, and then an ESP block is performed under ultrasound guidance (0.25% levobupivacaine 20 ml). Place a catheter under the erector spinae muscles and start intermittent administration (0.25% levobupivacaine). The catheter is removed in the morning 3 days after surgery. During surgery, anesthesia is maintained with remimazolam and remifentanil. 4) Remimazolam + epidural block (R-Epi) group An epidural catheter is placed in the upper chest before the introduction of general anesthesia, and continuous administration is started at the same time as the start of surgery. (0.25% levobupivacaine 4ml / hr) The catheter is removed in the morning 3 days after surgery. During surgery, anesthesia is maintained with remimazolam and remifentanil.

Outcome(s)

Primary Outcomepostoperative rest, pain assessment during movement (VAS), time to use additional analgesics after awakening, frequency of use, postoperative delirium
Secondary Outcomepostoperative nausea, vomiting, side effects

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaExclude cases that apply to any one of the following 1) ASA classification > 4 2) Patients with a history of hypersensitivity to the drugs used in this study 3) Patients who are judged to be inappropriate by the doctor responsible for the medical institution conducting the research

Related Information

Contact

public contact
Name Satoshi Sunaga
Address 1-1-1, Hondo, Akita-city, Akita, Japan 010-8543
Telephone 018-884-6175
E-mail s.sunaga@med.akita-u.ac.jp
Affiliation Akita University Graduate School of Medicine Anesthesia and Intensive Care Medicine
scientific contact
Name Satoshi Sunaga
Address 1-1-1, Hondo, Akita-city, Akita Japan
Telephone 018-884-6175
E-mail s.sunaga@med.akita-u.ac.jp
Affiliation Akita University Graduate School of Medicine Anesthesia and Intensive Care Medicine